F. Karmeli et al., SOMATOSTATIN EFFECTIVELY PREVENTS ETHANOL-INDUCED AND NSAID-INDUCED GASTRIC-MUCOSAL DAMAGE IN RATS, Digestive diseases and sciences, 39(3), 1994, pp. 617-625
The interrelationship between somatostatin and its synthetic analog, s
andostatin, with neuropeptides and inflammatory mediators, as well as
their protection of gastric mucosal damage, were tested in rats. Rats
were treated intragastrically with 1.0 ml of 96% ethanol with or witho
ut intravenous or intraperitoneal coadministration of somatostatin (1.
0 muM/kg). Mucosal damage was also induced by the administration of ei
ther indomethacin (30 mg/kg subcutaneously) with or without intravenou
s sandostatin (10 mug/rat), given 30 min prior to damage induction. So
matostatin levels in ethanol-damaged gastric mucosa were significantly
lower than in control rats. Substance P and vasoactive intestinal pep
tide (VIP) levels were significantly higher in the damaged mucosa in r
ats treated with ethanol, as was the mucosal generation of leukotriene
B4 (LTB4) and cysteinyl-containing leukotrienes. The coadministration
of somatostatin with ethanol significantly reduced gastric mucosal in
jury induced by ethanol alone. The protection of the mucosa was accomp
anied by reduction of mucosal substance P and VIP levels, as well as t
he generation of leukotrienes, an effect that was reversed by intraper
itoneal or intravenous coadministration of somatostatin antagonist, cy
clo-(7-aminoheptanoyl-PH-E-D-Trp-Lys-THR), 1.0 muM/100 g, with somatos
tatin (1.0 muM/kg) and ethanol. When given by itself somatostatin sign
ificantly reduced mucosal leukotriene generation compared with their g
eneration in saline-treated rats. Sandostatin completely abolished gas
tric mucosal damage induced by indomethacin administration. In rats tr
eated with somatostatin and indomethacin, this effect was accompanied
by reduction of mucosal leukotriene generation. Administration of sand
ostatin to pylorus-ligated rats significantly reduced gastric acid out
put. It is suggested that somatostatin may be involved in the pathogen
esis of acute ethanol- and NSAID-induced gastric mucosal injury and th
at part of its protective effect involves interrelationships with the
neuropeptides, substance P and VIP, as well as inhibition of mucosal l
eukotriene production.